检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial.

John R Jones,David A Cairns,Tom Menzies,Charlotte Pawlyn,Faith E Davies,Rachel Sigsworth,Annamaria Brioli,Matthew W Jenner,Martin F Kaiser,Catherine Olivier, Molly Reed,Mark T Drayson,Roger G Owen,Kevin D Boyd,Gordon Cook,Gareth J Morgan,Graham H Jackson

EClinicalMedicine（2023）

引用 0|浏览43
暂无评分
摘要
Primary financial support was from Cancer Research UK [C1298/A10410].
更多
查看译文
关键词
second primary malignancies,transplant,non-eligible
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要